Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
2.740
+0.040 (1.48%)
At close: Mar 9, 2026, 4:00 PM EDT
2.613
-0.127 (-4.64%)
After-hours: Mar 9, 2026, 6:54 PM EDT
Lantern Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 31 | 34 | 47 | 66 | 89 | 120 | |
| Market Cap Growth | -34.38% | -26.05% | -29.06% | -26.55% | -25.41% | - | |
| Enterprise Value | 18 | 7 | 2 | 8 | 16 | 99 | |
| Last Close Price | 2.70 | 3.19 | 4.28 | 6.04 | 7.98 | 19.25 | |
| PB Ratio | 3.11 | 1.62 | 1.14 | 1.17 | 1.25 | 6.08 | |
| P/TBV Ratio | 3.15 | 1.62 | 1.14 | 1.17 | 1.25 | 6.08 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -1.28 | -1.12 | -1.00 | -0.98 | -0.98 | -0.97 | |
| Net Debt / EBITDA Ratio | 0.62 | 1.07 | 2.30 | 3.82 | 6.09 | 3.24 | |
| Net Debt / FCF Ratio | 0.73 | 1.33 | 2.86 | 4.31 | 6.65 | 3.37 | |
| Quick Ratio | 3.06 | 5.57 | 15.74 | 19.94 | 30.48 | 34.81 | |
| Current Ratio | 3.33 | 5.83 | 16.18 | 20.99 | 31.26 | 36.64 | |
| Return on Equity (ROE) | -104.58% | -66.93% | -32.93% | -22.35% | -27.09% | -57.24% | |
| Return on Assets (ROA) | -55.99% | -40.12% | -21.80% | -13.59% | -15.36% | -33.89% | |
| Return on Capital Employed (ROCE) | -205.20% | -104.60% | -43.60% | -25.80% | -16.20% | -29.80% | |
| Earnings Yield | -62.72% | -60.41% | -34.31% | -21.75% | -13.85% | -4.94% | |
| FCF Yield | -55.90% | -51.81% | -30.88% | -19.51% | -11.88% | -4.74% | |
| Buyback Yield / Dilution | -0.29% | 0.74% | 0.08% | 0.50% | -153.31% | -117.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.